2-AMINO-2-(2,4-DIFLUOROPHENYL)ACETIC ACID HCL, 95.0%, 5g

(3-(2-Methoxy-2-oxoethoxy)phenyl)boronic acid, 95.0%, 1g

3-Methoxycyclobutanone, 95.0%, 500mg

(2E)-3-(2,5-dimethoxyphenyl)-1-(4-ethoxyphenyl)prop-2-en-1-one, 95.0%, 10g

Columna HPLC NUCLEODUR® NH2-RP 5 µm, 250 mm, 4 mm, 1 Pieza(s)

1,2,3,6-Tetrahydropyridine-4-boronic acid, pinacol ester, hydrochloride, 95.0%, 25g

(4-Chloro-2-hydroxyphenyl)boronic acid, 97%, 100g

1H,1H-Perfluoro-1-dodecanol, 96.0%, 25g

3-amino-N,N-diethyl-4-[(2-hydroxyethyl)amino]-Benzenesulfonamide, 97%, 100mg

(2-Propyl-benzoimidazol-1-yl)-acetic acid, 250mg

TERT-BUTYL 4-METHYL-3,5-DIOXO-2-AZABICYCLO[2.2.2]OCTANE-2-CARBOXYLATE, 90.0%, 500mg

4-methylbenzene-1-sulfonic acid; 4-methylpiperidin-3-one, 97.0%, 1g

1-(2-Chloroethoxy)-4-nitrobenzene>98.0%(GC)5g